Zacks Research Has Positive Outlook of EMN FY2026 Earnings

Key Points

• Zacks Research raised Eastman Chemical’s FY2026 EPS estimate to $6.39 from $5.81, close to the $6.50 analyst consensus, signaling a more positive earnings outlook.
• Eastman Chemical beat quarterly expectations with EPS of $1.97 versus the $1.82 consensus, while revenue rose 9.9% year over year to $2.51 billion.
• The company declared a quarterly dividend of $0.84 per share, equivalent to $3.36 annually and a 4.5% yield; analysts collectively rate the stock “Moderate Buy,” with an average price target of $79.17.

Eastman Chemical Company (NYSE:EMN - Free Report) - Equities research analysts at Zacks Research boosted their FY2026 earnings per share estimates for shares of Eastman Chemical in a research note issued on Thursday, August 13th. Zacks Research analyst Team now anticipates that the basic materials company will earn $6.39 per share for the year, up from their previous forecast of $5.81. The consensus estimate for Eastman Chemical's current full-year earnings is $6.50 per share.

A number of other equities analysts have also recently issued reports on EMN. UBS Group upped their price target on shares of Eastman Chemical from $89.00 to $92.00 and gave the stock a "buy" rating in a research note on Monday, August 3rd. The Goldman Sachs Group reaffirmed a "neutral" rating and issued a $75.00 target price on shares of Eastman Chemical in a report on Thursday, July 16th. Wall Street Zen upgraded shares of Eastman Chemical from a "hold" rating to a "buy" rating in a report on Saturday, August 1st. Morgan Stanley decreased their price objective on shares of Eastman Chemical from $83.00 to $79.00 and set an "overweight" rating for the company in a report on Thursday, July 2nd. Finally, Royal Bank Of Canada lifted their target price on Eastman Chemical from $69.00 to $74.00 and gave the stock a "sector perform" rating in a report on Wednesday, August 5th. Seven equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $79.17.

Eastman Chemical Price Performance

Shares of NYSE:EMN opened at $74.05 on Monday. The business has a fifty day moving average price of $70.45 and a 200-day moving average price of $72.52. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.50 and a quick ratio of 0.76. The company has a market capitalization of $8.47 billion, a PE ratio of 19.28, a PEG ratio of 0.91 and a beta of 1.06. Eastman Chemical has a 1-year low of $56.11 and a 1-year high of $83.47.

Eastman Chemical (NYSE:EMN - Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The basic materials company reported $1.97 earnings per share for the quarter, beating analysts' consensus estimates of $1.82 by $0.15. Eastman Chemical had a return on equity of 9.46% and a net margin of 4.99%.The company had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.40 billion. During the same quarter last year, the company earned $1.60 EPS. The firm's revenue for the quarter was up 9.9% on a year-over-year basis. Eastman Chemical has set its Q3 2026 guidance at 1.970-1.970 EPS.

Eastman Chemical Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 7th. Stockholders of record on Tuesday, September 15th will be given a dividend of $0.84 per share. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a $3.36 annualized dividend and a dividend yield of 4.5%. Eastman Chemical's dividend payout ratio is presently 87.50%.

Hedge Funds Weigh In On Eastman Chemical

Several institutional investors have recently made changes to their positions in the business. Lido Advisors LLC increased its holdings in shares of Eastman Chemical by 0.6% in the fourth quarter. Lido Advisors LLC now owns 20,313 shares of the basic materials company's stock valued at $1,297,000 after purchasing an additional 125 shares during the last quarter. Altshuler Shaham Ltd boosted its stake in Eastman Chemical by 36.9% during the first quarter. Altshuler Shaham Ltd now owns 538 shares of the basic materials company's stock worth $41,000 after buying an additional 145 shares during the last quarter. Generali Asset Management SPA SGR boosted its stake in Eastman Chemical by 9.6% during the fourth quarter. Generali Asset Management SPA SGR now owns 1,700 shares of the basic materials company's stock worth $109,000 after buying an additional 149 shares during the last quarter. UMB Bank n.a. grew its holdings in Eastman Chemical by 6.2% in the 4th quarter. UMB Bank n.a. now owns 2,571 shares of the basic materials company's stock valued at $164,000 after buying an additional 150 shares in the last quarter. Finally, Jacobi Capital Management LLC increased its stake in shares of Eastman Chemical by 3.2% in the 4th quarter. Jacobi Capital Management LLC now owns 4,982 shares of the basic materials company's stock worth $318,000 after acquiring an additional 153 shares during the last quarter. Institutional investors own 83.65% of the company's stock.

More Eastman Chemical News

Here are the key news stories impacting Eastman Chemical this week:

• Positive Sentiment: Zacks raised its Q3 2026 EPS forecast to $1.95 from $1.69, Q4 2026 to $1.38 from $1.33, Q1 2027 to $1.61 from $1.52, Q2 2027 to $1.73 from $1.69, and Q3 2027 to $1.77 from $1.70. Zacks also lifted its FY2027 estimate to $6.76 from $6.59, indicating stronger expected earnings momentum over the next several quarters. Eastman Chemical earnings estimate revisions
• Neutral Sentiment: The revisions leave Zacks’ FY2028 EPS forecast at $6.93, above the current-year consensus estimate of $6.43 but below its previous $7.09 forecast. Zacks also trimmed Q2 2028 EPS to $1.78 from $1.84 and Q4 2027 to $1.65 from $1.67, suggesting some longer-term caution despite the improved near-term outlook. Eastman Chemical earnings estimate revisions
• Positive Sentiment: A separate Zacks analysis described EMN as a strong value stock, which may support investor interest given the company’s earnings outlook and valuation profile. However, the article is a general style-rating assessment rather than a new operating or financial announcement. Here's Why Eastman Chemical is a Strong Value Stock

About Eastman Chemical

Eastman Chemical Company NYSE: EMN is a global specialty materials company that develops, manufactures and markets a broad range of advanced materials, chemicals and fibers. Its product portfolio spans performance additives, functional products, and engineered plastics designed to enhance the durability, appearance and performance of end products across diverse industries.

The company's main business activities include the production of specialty chemicals used in adhesives, coatings, building materials and consumer care applications, as well as high-performance plastics for packaging, automotive and electronics markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source